AMTI Applied Molecular Transport Inc

Price (delayed)

$40.80

Market cap

$1.44B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.91

Enterprise value

$1.43B

Sector: Healthcare
Industry: Biotechnology

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, ...

Highlights

AMTI's EPS is up by 38% since the previous quarter and by 24% year-on-year
Applied Molecular Transport's debt has decreased by 8% from the previous quarter
The company's quick ratio has surged by 110% YoY but it fell by 11% QoQ
The net income has plunged by 137% YoY and by 20% from the previous quarter
Applied Molecular Transport's equity has decreased by 12% from the previous quarter

Key stats

What are the main financial stats of AMTI
Market
Shares outstanding
35.25M
Market cap
$1.44B
Enterprise value
$1.43B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.81
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$66.56M
EBITDA
-$64.72M
Free cash flow
-$64.21M
Per share
EPS
-$2.91
Free cash flow per share
-$2.81
Book value per share
$3.77
Revenue per share
$0
TBVPS
$6.13
Balance sheet
Total assets
$140.18M
Total liabilities
$8.51M
Debt
$636,000
Equity
$131.67M
Working capital
$123.84M
Liquidity
Debt to equity
0
Current ratio
17.16
Quick ratio
16.96
Net debt/EBITDA
0.08
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-53.4%
Return on equity
-74%
Return on invested capital
-63%
Return on capital employed
-50.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMTI stock price

How has the Applied Molecular Transport stock price performed over time
Intraday
-2.49%
1 week
-3.13%
1 month
-36.35%
1 year
N/A
YTD
32.6%
QTD
-7.29%

Financial performance

How have Applied Molecular Transport's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$66.68M
Net income
-$66.56M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 137% YoY and by 20% from the previous quarter
Applied Molecular Transport's operating income has plunged by 136% YoY and by 20% from the previous quarter

Growth

What is Applied Molecular Transport's growth rate over time

Valuation

What is Applied Molecular Transport stock price valuation
P/E
N/A
P/B
10.81
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
AMTI's EPS is up by 38% since the previous quarter and by 24% year-on-year
Applied Molecular Transport's equity has decreased by 12% from the previous quarter

Efficiency

How efficient is Applied Molecular Transport business performance
The return on invested capital has surged by 76% year-on-year and by 10% since the previous quarter
The ROE has grown by 48% from the previous quarter
Applied Molecular Transport's ROA has increased by 41% YoY and by 4.3% from the previous quarter

Dividends

What is AMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMTI.

Financial health

How did Applied Molecular Transport financials performed over time
The company's quick ratio has surged by 110% YoY but it fell by 11% QoQ
The current ratio has soared by 107% YoY but it has decreased by 12% QoQ
Applied Molecular Transport's debt is 100% less than its equity
Applied Molecular Transport's equity has decreased by 12% from the previous quarter
Applied Molecular Transport's debt has decreased by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.